Incomplete thyroid ultrasound (US) radiology reports cause "confusion and discrepancy" among specialists about the risk of malignancy and the necessity of biopsy, according to findings reported in the American Journal of Roentgenology.

A new proposal released Oct. 18 by the FDA to strengthen cybersecurity protection for medical devices, including medical imaging equipment, will supersede a guidance originally issued in 2014.

Formativ Health, a technology-enabled health services company focused on transforming the patient-provider experience, announced today its partnership with Conversa Health to enable personalized patient care through automated digital conversations.

Right ventricular (RV) strain analysis could be a useful addition to existing methods of risk assessment in patients with acute decompensated heart failure (ADHF), according to recent research that identified RV longitudinal strain from the free wall (RV-fwLS) as an independent predictor of cardiac events in the demographic.

Artificial intelligence could be key to driving down emergency room visits over the next five years, according to one research company's crystal ball. 

A $1.6 million, four-year grant from the National Cancer Institute of the National Institutes of Health (NIH) was awarded to a researcher from Tulane University in Louisiana to develop a prostate cancer scanner that can check whether all traces of cancer have been removed after surgery, according to The Associated Press.

In patients with liver cirrhosis, four-dimensional (4D) flow MRI can help indicate the risk of bleeding in gastroesophageal varices and reduce the need for invasive endoscopy procedures, wrote authors of an Oct. 16 Radiology study.

Avinger announced on Oct. 18 its Pantheris SV atherectomy device has gained CE mark approval, allowing it to be sold commercially in Europe. The system extends the plaque-removing technique for peripheral artery disease to smaller vessels with diameters between 2 and 4 millimeters.

Healthcare providers are always working to improve patient awareness and engagement when it comes to breast cancer screening—but raunchy emails don’t appear to be the answer.

Primary care physicians who order a large number of one low-value screening test tend to order large numbers of other low-value screening tests as well, according to a new study published in JAMA Network Open. The authors suggested that high-intensity interventions focused on these physicians may be one way to reduce such low-value care going forward.